CD47 Blockade Triggers T Cell–Mediated Destruction of Immunogenic Tumors Using syngeneic immunocompetent mouse tumor models, investigators revealed that the therapeutic effects of CD47 blockade depend on dendritic cell but not macrophage cross-priming of T cell responses. The therapeutic effects of anti-CD47 antibody therapy were abrogated in T cell–deficient mice. [Nat Med] Abstract | Press Release IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses Scientists found that IL-36γ stimulated CD8+ T cells, NK cells, and γδ T cells synergistically with TCR signaling and/or IL-12. Importantly, IL-36γ exerted profound antitumor effects in vivo and transformed the tumor microenvironment in favor of tumor eradication. [Cancer Cell] Abstract | Graphical Abstract The Transcription Factor ATF7 Mediates Lipopolysaccharide-Induced Epigenetic Changes in Macrophages Involved in Innate Immunological Memory Researchers identified an important role for the stress-response transcription factor ATF7 in innate immunological memory. ATF7 suppressed a group of genes encoding factors involved in innate immunity in macrophages by recruiting the histone H3K9 dimethyltransferase G9a. [Nat Immunol] Abstract | Press Release Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney Scientists phenotypically and functionally characterized murine kidney CD4−CD8− (double-negative) T cells in the steady state and in response to ischemia-reperfusion injury. [J Am Soc Nephrol] Abstract Triglyceride-Rich Lipoproteins Modulate the Distribution and Extravasation of Ly6C/Gr1low Monocytes The authors report that in the presence of elevated levels of triglyceride-rich lipoproteins, induced by administration of poloxamer 407, the blood numbers of non-classical Ly6C/Gr1low monocytes drop, while the number of bone marrow progenitors remains similar. [Cell Rep] Full Article | Graphical Abstract | Press Release Efficacy of Systemic Adoptive Transfer Immunotherapy Targeting NY-ESO-1 for Glioblastoma Investigators utilized human glioblastoma cell cultures to induce expression of New York–esophageal squamous cell carcinoma (NY-ESO-1) following in vitro treatment with the demethylating agent decitabine. They examined the in vivo application of this immune therapy using an intracranially implanted xenograft model for in situ T cell trafficking, survival, and tissue studies. [Neuro Oncol] Abstract | Press Release Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation Researchers found that a short synthetic peptide able to inhibit FOXP3/NFAT interaction impaired suppressor activity of conventional regulatory T cells in vitro. Specific inhibition of FOXP3/NFAT interaction with this inhibitory peptide revealed that FOXP3 downregulates NFAT-driven promoter activity of CD40L and IL-17. [J Immunol] Abstract Plasma Phospholipid Transfer Protein (PLTP) Modulates Adaptive Immune Functions through Alternation of T Helper Cell Polarization Scientists demonstrated that PLTP deficiency in mice has a profound effect on CD4+ Th0 cell polarization, with a shift towards the anti-inflammatory Th2 phenotype under both normal and pathological conditions. [Cell Mol Immunol] Abstract Don’t forget to subscribe to Human Immunology News and Immunology of Infectious Disease News! |